Published • loading... • Updated
Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
Summary by BizToc
5 Articles
5 Articles
New trial results with a drug for head and neck cancer send Genmab's share price up.
·Copenhagen, Denmark
Read Full Article
Genmab Shares Hit Record as Cancer Trial Extends Drugmaker’s Run
Genmab A/S shares jumped to an all-time high after an experimental cancer treatment cut the risk of death by 50% in a late-stage trial, adding to a string of positive results that have boosted confidence in the Danish drugmaker’s pipeline.
·New York, United States
Read Full Article
New trial results with a drug for head and neck cancer send Genmab's share price up
·Copenhagen, Denmark
Read Full Article
For the third time in a month, Genmab was able to present good data, and it was rewarded on Wednesday. This was reflected in the C25 index, which rose 2.80 percent.
Coverage Details
Total News Sources5
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
